Section 16-18-2-199 - [Effective 7/1/2024] "Legend drug""Legend drug", for purposes of IC 16-42, means a drug that is:
(1) subject to 21 U.S.C. 353(b)(1); or(2) listed in the Prescription Drug Product List as: (A) published in United States Department of Health and Human Services Approved Drug Products with Therapeutic Equivalence Evaluations, Tenth Edition, (1990); and(B) revised in United States Department of Health and Human Services, Approved Drug Products with Therapeutic Equivalence Evaluations, Cumulative Supplement to the Tenth Edition, Number 10 (1990).Pre-1993 Recodification Citations: 16-6-8-2(k); 16-6-12-3.
Amended by P.L. 9-2024,SEC. 370, eff. 7/1/2024.Amended by P.L. 10-2020,SEC. 1, eff. 1/1/2021.Amended by P.L. 131-2014, SEC. 6, eff. 7/1/2014.As added by P.L. 2-1993, SEC.1.This section is set out more than once due to postponed, multiple, or conflicting amendments.